NARA Discovery
Article Details
← Back to Search Results
Journal Article

First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases

Eric Helmer; Mark Watling; Emma Jones; Dominique Tytgat; Mark Jones; Rodger Allen; Andrew Payne; Annelize Koch; Eugene Healy
European Journal of Clinical Pharmacology · Vol. 73, Issue 5 · pp. 581-591 · 2017

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Pharmacology
PublisherSpringer
Publication Date2017-05-01
Publication Year2017
Volume73
Issue5
Pages581-591
Document TypeJournal Article
Print ISSN0031-6970
eISSN1432-1041
DOI10.1007/s00228-017-2205-7

Access Information

NARA Access Coverage1968-01-01~Current
Journal Homepagehttps://www.springer.com/journal/228
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.